tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Adamas Pharmaceuticals's activity chart (see below) currently has 61 price targets and 63 ratings on display.
Analysts average stock forecasts to be materialized ratio is 37.97% with an average time for these price targets to be met of 164.76 days.
Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 18-Nov-2021. First documented stock forecast 05-May-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Nov-2017
$8.5
$0.28 (3.41%)
4 years 10 months 14 days ago
(18-Nov-2021)
0/3 (0%)
$0.33 (4.04%)
Buy Since 12-Jan-2016
$8
$-0.22 (-2.68%)
$7
4 years 11 months 19 days ago
(13-Oct-2021)
4/5 (80%)
$-0.07 (-0.87%)
95
Buy Since 17-Aug-2017
$14
4 years 11 months 19 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Hold Since 13-Oct-2021
$8
$-0.22 (-2.68%)
$10
4 years 11 months 19 days ago
(13-Oct-2021)
1/7 (14.29%)
$-0.07 (-0.87%)
6
Buy
$6
$-2.22 (-27.01%)
$20
4 years 11 months 20 days ago
(12-Oct-2021)
0/2 (0%)
$3.2 (23.94%)
What is ADMS (Adamas Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ADMS (Adamas Pharmaceuticals)?
Which analyst has the most public recommendations on ADMS (Adamas Pharmaceuticals)?
Which analyst is the currently most bullish on ADMS (Adamas Pharmaceuticals)?
Which analyst is the currently most reserved on ADMS (Adamas Pharmaceuticals)?
